![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
H Canton, RB Emeson, EL Barker, JR Backstrom, JT Lu, MS Chang and E Sanders-Bush
Department of Pharmacology, Vanderbilt University School of Medicine, Nashvile, Tennessee 37232, USA.
The actions of the neurotransmitter 5-hydroxytryptamine (5-HT) (serotonin) are mediated by multiple receptor subtypes. One of the prominent serotonin receptors in the brain is the 5-HT2C receptor (5- HT2C-R). We report the occurrence of a second 5-HT2C-R transcript, first identified using S1 nuclease protection of total RNA isolated from the choroid plexus. Analyses of the distribution of these two RNAs revealed that the short form is expressed in the same structures as the 5-HT2C-R mRNA, including choroid plexus, striatum, hippocampus, hypothalamus, olfactory tubercles, and spinal cord. Cloning and sequence analyses revealed a second cDNA with a 95-nt deletion in the region coding for the putative second intracellular loop and the fourth transmembrane domain of the 5-HT2C-R. This deletion leads to a frameshift in the coding sequence and the introduction of a premature stop codon. The predicted truncated protein (5-HT2C-tr) contains 172 amino acids, with 153 residues at the amino terminus, identical to the 5-HT2C-R, and 19 carboxyl-terminal amino acids that are unique. Although antibodies specific to the 5-HT2C-tr protein showed that the truncated form is expressed in a transfected fibroblast cell model system, there was no serotonergic ligand binding activity or phosphoinositide hydrolysis. Analyses of the 5-HT2C-R gene revealed that the two transcripts arise from a single gene by differential splicing using alternative donor sites and a common 3'-splice acceptor. Polymerase chain reaction amplification of mouse and human brain cDNAs demonstrated the occurrence of the same splicing patterns in these species. Although this study demonstrates tissue-specific expression of two 5-HT2C mRNA splice variants in rat, mouse, and human, the significance of the truncated form in these three species remains to be established.
This article has been cited by other articles:
|
|
 |
|
  K. J. Miller SEROTONIN 5-HT2C RECEPTOR AGONISTS: POTENTIAL FOR THE TREATMENT OF OBESITY Mol. Interv., October 1, 2005; 5(5): 282 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Vitali, E. Basyuk, E. Le Meur, E. Bertrand, F. Muscatelli, J. Cavaille, and A. Huttenhofer ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs J. Cell Biol., June 6, 2005; 169(5): 745 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Perron, P. Sarret, L. Gendron, T. Stroh, and A. Beaudet Identification and Functional Characterization of a 5-Transmembrane Domain Variant Isoform of the NTS2 Neurotensin Receptor in Rat Central Nervous System J. Biol. Chem., March 18, 2005; 280(11): 10219 - 10227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Flomen, J. Knight, P. Sham, R. Kerwin, and A. Makoff Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene Nucleic Acids Res., April 15, 2004; 32(7): 2113 - 2122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sanders-Bush, H. Fentress, and L. Hazelwood Serotonin 5-HT2 Receptors: Molecular and Genomic Diversity Mol. Interv., September 1, 2003; 3(6): 319 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Catalano, T. Kyriakou, J. Chen, A. Easton, and E. W. Hillhouse Regulation of Corticotropin-Releasing Hormone Type 2 Receptors by Multiple Promoters and Alternative Splicing: Identification of Multiple Splice Variants Mol. Endocrinol., March 1, 2003; 17(3): 395 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Maas, S. Patt, M. Schrey, and A. Rich Underediting of glutamate receptor GluR-B mRNA in malignant gliomas PNAS, November 15, 2001; (2001) 251531398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cavaillé, K. Buiting, M. Kiefmann, M. Lalande, C. I. Brannan, B. Horsthemke, J.-P. Bachellerie, J. Brosius, and A. Hüttenhofer Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization PNAS, November 29, 2000; (2000) 250426397. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Liu, R. B. Emeson, and C. E. Samuel Serotonin-2C Receptor Pre-mRNA Editing in Rat Brain and in Vitro by Splice Site Variants of the Interferon-inducible Double-stranded RNA-specific Adenosine Deaminase ADAR1 J. Biol. Chem., June 25, 1999; 274(26): 18351 - 18358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. NISWENDER, E. SANDERS-BUSH, and R. B. EMESON Identification and Characterization of RNA Editing Events within the 5-HT2C Receptor Ann. N.Y. Acad. Sci., December 15, 1998; 861(1): 38 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, M. J. Dresser, J. K. Chun, P. C. Babbitt, and K. M. Giacomini Cloning and Functional Characterization of a Rat Renal Organic Cation Transporter Isoform (rOCT1A) J. Biol. Chem., June 27, 1997; 272(26): 16548 - 16554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Backstrom, R. D. Price, D. T. Reasoner, and E. Sanders-Bush Deletion of the Serotonin 5-HT2C Receptor PDZ Recognition Motif Prevents Receptor Phosphorylation and Delays Resensitization of Receptor Responses J. Biol. Chem., July 28, 2000; 275(31): 23620 - 23626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cavaille, K. Buiting, M. Kiefmann, M. Lalande, C. I. Brannan, B. Horsthemke, J.-P. Bachellerie, J. Brosius, and A. Huttenhofer From the Cover: Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization PNAS, December 19, 2000; 97(26): 14311 - 14316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Maas, S. Patt, M. Schrey, and A. Rich Underediting of glutamate receptor GluR-B mRNA in malignant gliomas PNAS, December 4, 2001; 98(25): 14687 - 14692. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
